Klonopin is the brand name for clonazepam, a long-acting benzodiazepine FDA-approved for panic disorder and seizure disorders. It produces a smoother, longer-lasting calming effect than alprazolam because of its 30 to 40 hour half-life. It carries the full benzodiazepine class risks: dependence within weeks of regular use, severe withdrawal including seizures, and fatal respiratory depression when combined with opioids or alcohol.
What Klonopin is
Klonopin is the brand name for clonazepam, a medication in the benzodiazepine class. It enhances the effect of GABA at GABA-A receptors throughout the central nervous system. It was approved by the FDA in 1975 for seizure disorders and is also approved for panic disorder. Generic clonazepam is widely available. The MedlinePlus drug information page for clonazepam covers consumer-facing essentials.
The longer reference for the benzodiazepine class is Benzodiazepines for anxiety.
What it does
Clonazepam enhances GABA at GABA-A receptors. The acute effects are felt within 30 to 60 minutes: reduced anxiety, muscle relaxation, mild sedation. The half-life is 30 to 40 hours, much longer than alprazolam (6 to 12 hours) or lorazepam (10 to 20 hours).
The longer half-life produces a smoother effect across the day with twice-daily or even once-daily dosing, and it reduces the inter-dose withdrawal that's common with alprazolam. The trade-off is that the drug accumulates over the first several days of regular use and clears slowly when stopped, which can produce a more gradual but still significant withdrawal arc.
What it feels like
Patients describe a felt calming within 30 to 60 minutes after a dose, with effect persisting for many hours. Muscle tension softens. Sleep is often easier. With twice-daily dosing, the felt effect is more even across the day than with alprazolam.
Sedation, particularly in the first days, is more pronounced than with alprazolam at equivalent anxiolytic doses. This often improves with continued use but limits initial dosing.
When it's chosen
When a benzodiazepine is appropriate (a narrow set of situations), clonazepam is often preferred over alprazolam for:
- Panic disorder in patients who haven't responded to SSRIs and require a benzodiazepine component
- Patients who would otherwise need three-times-daily alprazolam, where the longer-acting agent reduces inter-dose rebound
- Short-term bridging while an SSRI takes effect, in patients where the longer half-life is preferable
Even for these situations, the American Psychiatric Association and the NIMH anxiety disorders overview recommend SSRIs, SNRIs, or CBT as first-line, with benzodiazepines used only when first-line approaches haven't worked or as time-limited adjuncts.
Typical dosing and timeline
Starting dose for panic disorder is typically 0.25 mg twice daily. Doses can be titrated, but the dependence and tolerance risk rises with daily use beyond two to four weeks. The typical effective dose for panic disorder is 0.5 to 2 mg daily.
When used as a short-term bridge while an SSRI takes effect, two to six weeks is a reasonable window; beyond that, the risk-benefit balance shifts.
Side effects and cautions
Sedation, slowed cognition, and impaired motor coordination are dose-related. Older adults are particularly vulnerable; benzodiazepines are on the American Geriatrics Society Beers Criteria as medications to avoid except in narrow situations.
The FDA boxed warning applies: concomitant use with opioids increases the risk of fatal respiratory depression; physical dependence develops within weeks; abrupt discontinuation can produce severe withdrawal including seizures. Alcohol potentiates all of these risks.
What Klonopin doesn't do
Klonopin doesn't treat the underlying anxiety disorder. The acute effect is symptomatic relief. When the dose effect wanes, the underlying condition is unchanged.
Klonopin doesn't address the cognitive patterns of anxiety in the way CBT does. For panic disorder specifically, exposure therapy produces more durable improvement than any medication used alone.
Comparison with related medications
Compared with alprazolam, clonazepam has slower onset and a much longer half-life, which smooths the dosing arc and reduces inter-dose rebound. Compared with lorazepam, clonazepam's longer duration allows fewer doses per day, but lorazepam is preferred in patients with significant liver disease and in many emergency settings. The class picture, including the case for first-line non-benzodiazepine treatment, is in Benzodiazepine vs SSRI for panic.